ESSO Course on Peritoneal Surface Malignancy

Size: px
Start display at page:

Download "ESSO Course on Peritoneal Surface Malignancy"

Transcription

1 ESSO Course on Peritoneal Surface Malignancy In partnership with The Christie School of Oncology October 2015 MANCHESTER (UK)

2 ESSO Course on Peritoneal Surface Malignancy Chair: Sarah O Dwyer, The Christie NHS Foundation Trust, Manchester, UK Co-Chair: Santiago González-Moreno, MD Anderson Cancer Center, Madrid, SP Faculty Members Thomas Bacheitner- Hofmann, Medical University of Vienna, AT Norman Carr, Basingstoke and North Hampshire Hospital, Basingstoke, UK Tom Cecil, Basingstoke and North Hampshire Hospital, Basingstoke, UK Marcello Deraco, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, IT Charles Honoré, Institut de Cancérologie Gustave Roussy, Villejuif, FR Brendan Moran, Basingstoke and North Hampshire Hospital, Basingstoke, UK Pompiliu Piso, St. John of God Hospital, Regensburg, DE Beate Rau,Charité Campus Mitte, Berlin, DE Josefin Segelman, Karolinska Institut, Solna, Stockholm, SE Paul H Sugarbaker, Washington Cancer Center, Washington, USA Kurt Van der Speeten, Ziekenhuis Oost-Limburg, Genk, BE Vic Verwaal, The Netherlands Cancer Institute, Amsterdam, NL Willemien van Driel, Netherlands Cancer Institute, Amsterdam, NL Local Faculty Omar Aziz Rahul Deshpande Paul Fulford Vidya Kasipandian Rohit Kochhar Andrew Renehan Mark Saunders Chelliah Selvasekar Malcolm Wilson

3 Aim of the course A comprehensive workshop on Peritoneal Surface Malignancies addressing current treatments for specific tumour groups and future challenges for developing services in different health care settings. The course will focus on delivering evidence-based clinical practice and achieving quality assured outcomes for patients undergoing abdominal and pelvic cytoreductive surgery and intraperitoneal chemotherapy. Topics covered Neoplasia of the appendix: pathology, diagnosis and clinical pathways Peritoneal Surface Malignancies: outcomes for colorectal, ovarian, gastric cancers and mesothelioma Surgical techniques: tips and tricks to achieve complete cytoreduction Intraperitoneal chemotherapy: why, what, who and how Setting up a service: challenges and opportunities Ideal Course candidates Consultant Surgeons/gynaecologists/oncologists Senior residents/fellows surgery/gynaecology/oncology Senior Nurse Practitioners in PSM/oncology Educational methods Live surgical session with interactive discussion Video sessions/workshops on surgical technique and HIPEC Plenary lectures MDT case management Interactive voting on key topics Course Venue The Christie NHS Foundation Trust Wilmslow Road Manchester, M20 4BX United Kingdom

4 Course coordination Ana Galán European Society of Surgical Oncology (ESSO) . Application Procedure Please go to (education/projects & courses) to complete your application and apply for the course. Participation fee The participation fee is 650 for ESSO members and 800 for non-members. It includes registration for the 2-day course,coffee breaks and lunches and a social dinner. Accreditation An application for accreditation has been submitted to the European Accreditation Council for CME (EACCME) of the European Union of Medical Specialists (UEMS).

5 Programme Thursday 08 October Welcome 08:15-08:30 Aims and objectives; global guidelines S. O Dwyer, S.González-Moreno Generic challenges in PSM Service delivery for PSM Moderators: B. Moran, P. Piso 08:30-08:45 The European picture: reference centres and networks S.González-Moreno 08:45-09:00 Setting up a service: challenges and opportunities T. Bacheitner - Hofman 09:00-09:05 Discussion 09:05-09:35 Imaging for PSM: what the MDT should look for R. Kochar 09:35-09:40 Discussion 09:40-10:10 Keynote address: Evidence base and principles of management of peritoneal metastases P. Sugarbaker Chemotherapy Moderators: A. Renehan, V. Verwaal 10:10-10:25 HIPEC: overview of current regimes K. Van der Speeten 10:25-10:30 Can we reach a consensus: voting 10:30-10:40 Systemic chemotherapy: when how and what M. Saunders 10:40-10:50 EPIC: when how and what K. Van der Speeten 10:50-10:55 Can we reach a consensus: voting 10:55-11:15 Coffee break Perioperative support: tips and tricks Moderators: P. Fulford, T.B- Hofmann 11:15-11:30 Anaesthesia, critical care and pain management V. Kasipandian 11:30-11:45 Nutrition and enhanced recovery O. Aziz 11:45-12:00 Complications: how to avoid them B. Rau 12:00-12:15 Standardised recording of morbidity and mortality A. Reneham

6 12:15-12:30 Recommendations for follow up: why, who and for how long? T. Cecil 12:30-12:45 Discussion/voting Lunch Surgical techniques: tips and tricks Moderators: M. Wilson, S.G. Moreno 13:30-14:30 RUQ, R. Deshpande LUQ, P. Piso Central abdomen, M. Deraco Pelvis, T. Cecil MAS, C. Selvaseker HIPEC, K. Van der Speeten 14:30-14:45 Discussion 14:45-15:00 Coffee break Parallel sessions 15:00-17:00 Surgical techniques workshops/videos MDT case discussions Pathology workshop Nursing workshop Friday 09 October Disease specific challenges in PSM Appendix neoplasia Moderators: P. Fulford, M. Deraco 08:30-08:55 Keynote address: Concensus on the classification of appendix neoplasia N. Carr 08:55-09:00 Discussion 09:00-09:15 PMP Presentation and outcomes M. Wilson 09:15-09:30 Management of recurrence B.Moran 09:30-09:40 Discussion Surgery Moderators: S. O Dwyer, C. Selvaseker, A. Renehan, P. Fulford 09:40-10:15 Case Presentation and Live Surgery Coffee break

7 Colon and rectum Moderator: P. Piso 10:45-11:00 Patient selection and outcomes C. Honore 11:00-11:10 Selecting high risk patients J. Segelman 11:10-11:25 Future opportunities for CRS in colorectal cancer P.Sugarbaker 11:25-11:30 Discussion Surgery 11:30-12:00 Live surgery/ case discusion Mesothelioma Moderator: T. Cecil 12:00-12:40 Keynote address: Current and Future directions for the treatment of Peritoneal Mesothelioma M. Deraco 12:40-12:45 Discussion 12:45-13:45 Lunch (live surgery continues during lunch break) Gastric Cancer Moderator: C. Honore 13:45-14:10 Patient selection outcomes and future potential P. Piso 14:10-14:15 Discussion Surgery 14:15-14:30 Live surgery Ovarian Cancer Moderator: V. Verwaal 14:30-15:00 Keynote adress: Evidence base and recommendations for the treatment of ovarian peritoneal metastasis W. van Driel Discussion Palliative treatment for PSM Moderator: B.Rau 15:05-15:20 Strategies and outcomes from palliation K. Van der Speeten 15:20-15:25 Discussion 15:25-15:50 MDT Case discussions/live surgery update 15:50-16:00 Summary and Close

8 ESSO is grateful for the continuous support of its corporate sponsors European Society of Surgical Oncology (ESSO) Avenue E. Mounier 83 B 1200 Brussels Tel: +32 (0) Fax : +32 (0) Website :

2 nd ESSO Advanced Course on the Surgical and Medical Management of Melanoma

2 nd ESSO Advanced Course on the Surgical and Medical Management of Melanoma 2 nd ESSO Advanced Course on the Surgical and Medical Management of Melanoma Focus on stage III and IV melanoma In partnership with the Society of Surgical Oncology (SSO) 12-14 November 2015 ATHENS (GR)

More information

Enhanced Recovery after Surgery: Benefits, Challenges and Solutions for Implementation

Enhanced Recovery after Surgery: Benefits, Challenges and Solutions for Implementation Enhanced Recovery after Surgery: Benefits, Challenges and Solutions for Implementation 06-07 November 2015 MILAN (IT) IN PARTNERSHIP WITH Enhanced Recovery after Surgery: Benefits, Challenges and Solutions

More information

Highly Specialised Services. Peritoneal Oncology Service. Report September 2015

Highly Specialised Services. Peritoneal Oncology Service. Report September 2015 Highly Specialised Services Peritoneal Oncology Service Report September 2015 The Christie NHS Foundation Trust Wilmslow Road Withington Manchester M20 4BX http://www.christie.nhs.uk/our-services/colorectal-and-peritoneal-oncology-centre

More information

ESSO Advanced Course on Oncoplastic Breast Surgery 16-18 June 2016

ESSO Advanced Course on Oncoplastic Breast Surgery 16-18 June 2016 ESSO Advanced Course on Oncoplastic Breast Surgery 16-18 June 2016 BUDAPEST (HU) ESSO Advanced Course on Oncoplastic Breast Surgery Course directors Tibor Kovacs, Guy s and St. Thomas NHS Foundation Trust,

More information

Luis D. Carcorze Soto, MD PGY-3

Luis D. Carcorze Soto, MD PGY-3 Luis D. Carcorze Soto, MD PGY-3 Peritoneal Surface Malignancies Peritoneum Patient Selection Operative Technique HIPEC EPIC Primary: Primary Peritoneal Carcinoma Malignant Peritoneal Mesothelioma Metastatic:

More information

Peritoneal tumour service. Information for patients

Peritoneal tumour service. Information for patients Peritoneal tumour service Hyperthermic intraperitoneal chemotherapy (HIPEC) Information for patients Chemotherapy given into the abdomen during surgery is called intraoperative chemotherapy. This information

More information

Peritoneal Surface Malignancies. Ira Allen Jacobs, MD, FACS Surgical Oncology San Diego, CA

Peritoneal Surface Malignancies. Ira Allen Jacobs, MD, FACS Surgical Oncology San Diego, CA Peritoneal Surface Malignancies Ira Allen Jacobs, MD, FACS Surgical Oncology San Diego, CA Cancer dissemination routes Hematogenous metastases Lymphatic metastases Implants on peritoneal surfaces Surgically

More information

Faculty. 1 of 6 4/20/2016 12:14 PM. Home Register Program Abstracts Workshops Hotel

Faculty. 1 of 6 4/20/2016 12:14 PM. Home Register Program Abstracts Workshops Hotel 10th International Congress on Peritoneal Surface Malignancies - 1 of 6 4/20/2016 12:14 PM Home Register Program Abstracts Workshops Hotel Home Registration Program Meet the Professor Breakfast Sessions

More information

Intraoperative Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Volodymyr Labinskyy MD

Intraoperative Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Volodymyr Labinskyy MD Intraoperative Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Volodymyr Labinskyy MD KCHC 8/29/13 52 y.o. F presented with severe pain in the right back and right flank, sharp, 8 out of 10, for 7 days.

More information

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Now and the Future

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Now and the Future Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Now and the Future Mazin Al-kasspooles, MD Associate Professor of Surgery Division of Surgical Oncology Director, Regional Therapy

More information

Chirurgia Avanzata Del Carcinoma Ovarico Nuove Strategie A Confronto Ovarian Cancer Advanced Surgery New Strategies in Comparison

Chirurgia Avanzata Del Carcinoma Ovarico Nuove Strategie A Confronto Ovarian Cancer Advanced Surgery New Strategies in Comparison Peritoneal dissection and intraperitoneal chemotherapy under hyperthermic conditions. If you select the right patients long-term survival can be achieved. Chirurgia Avanzata Del Carcinoma Ovarico Nuove

More information

ONCOLOGY NURSING 7 TH ESO-EONS MASTERCLASS IN. 8-13 March 2014 Ermatingen (Lake Constance) Switzerland MASTERCLASS

ONCOLOGY NURSING 7 TH ESO-EONS MASTERCLASS IN. 8-13 March 2014 Ermatingen (Lake Constance) Switzerland MASTERCLASS MASTERCLASS Photo: Turm by Stephan Balkenhol - A Sculpture for Wolfsberg Photographer: Ralph Feiner, Architekturfotografie, Malans 7 TH ESO-EONS MASTERCLASS IN ONCOLOGY NURSING 8-13 March 2014 Ermatingen

More information

2nd International Symposium on Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)

2nd International Symposium on Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) 2nd International Symposium on Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) Wednesday Oct 7th, 2015 Congress Center (Hörsaal 1 3) Marien Hospital Herne Accreditation by the Medical Chamber

More information

Pseudomyxoma Peritonei Where are we in 2014?

Pseudomyxoma Peritonei Where are we in 2014? Pseudomyxoma Peritonei Where are we in 2014? Santiago González-Moreno, MD, PhD Head, Department of GI Surgical Oncology Peritoneal Surface Oncology Program Medical Director * * * * * * * * * * * * French

More information

Cytoreduction and hyperthermic intraperitoneal chemotherapy for the treatment of pseudomyxoma

Cytoreduction and hyperthermic intraperitoneal chemotherapy for the treatment of pseudomyxoma Medical Policy Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pseudomyxoma Peritonei and Peritoneal Carcinomatosis of Gastrointestinal Origin, and Peritoneal Mesothelioma

More information

15th Colorectal Day Programme

15th Colorectal Day Programme 15th Colorectal Day Programme 7TH OF JUNE 2016 AARHUS UNIVERSITY HOSPITAL, SKEJBY ENTRANCE 6, AUDITORIUM A www.crd.auh.dk Fotograf: Kristian Bang, AUH Dear friends and colleagues It is our pleasure to

More information

GOLNIK 17/06/10 COURSE ON LUNG CANCER AND MESOTHELIOMA. 17-18 June 2010 Golnik, Slovenia. Chair: T. Cufer, SI - G.L. Ceresoli, IT

GOLNIK 17/06/10 COURSE ON LUNG CANCER AND MESOTHELIOMA. 17-18 June 2010 Golnik, Slovenia. Chair: T. Cufer, SI - G.L. Ceresoli, IT ESO ADVANCED COURSES, SEMINARS AND SYMPOSIA GOLNIK 17/06/10 COURSE ON LUNG CANCER AND MESOTHELIOMA 17-18 June 2010 Golnik, Slovenia Chair: T. Cufer, SI - G.L. Ceresoli, IT AIM OF THE COURSE The incidence

More information

Advances in Surgical Oncology

Advances in Surgical Oncology 3-4 December 2015 Advances in Surgical Oncology 3 rd International Conference of the Medical University of Lublin 10 th anniversary of first Intraoperative Radiotherapy in Lublin 1 Scientific Chairman

More information

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) as Part of an Integrative Treatment Plan for Colorectal Peritoneal Carcinomatosis

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) as Part of an Integrative Treatment Plan for Colorectal Peritoneal Carcinomatosis Hyperthermic Intraperitoneal Chemotherapy (HIPEC) as Part of an Integrative Treatment Plan for Colorectal Peritoneal Carcinomatosis T. Christopher Windham, M.D., F.A.C.S. Medical Director, Florida Hospital

More information

RECTAL CANCER WHEN TO OPERATE

RECTAL CANCER WHEN TO OPERATE RECTAL CANCER WHEN TO OPERATE Operative Treatment Strategies... From Minimal to Maximal Champalimaud Foundation Lisbon, Portugal 7 th - 8 th November 2014 Organisation - Champalimaud Foundation Amjad Parvaiz

More information

Quick Facts about Appendix Cancer

Quick Facts about Appendix Cancer Quick Facts about Appendix Cancer What is the appendix? The appendix is a pouch-like tube attached to the first part of the large intestine (cecum). The appendix is about 10 centimetres long and has no

More information

International Symposium on Malignant Pleural Mesothelioma

International Symposium on Malignant Pleural Mesothelioma International Symposium on Malignant Pleural Mesothelioma LONDON 2015 Friday 6th & Saturday 7th November 2015 Jumeirah Carlton Tower Hotel Cadogan Place Knightsbridge London SW1X 9PY United Kingdom Dear

More information

Perioperative Intraperitoneal Chemotherapy. Annals of surgical oncology 17.9 (2010): 2370 7. Web. 17 Jan. 2015.

Perioperative Intraperitoneal Chemotherapy. Annals of surgical oncology 17.9 (2010): 2370 7. Web. 17 Jan. 2015. Alexander, H Richard et al. Treatment Factors Associated with Long-Term Survival after Cytoreductive Surgery and Regional Chemotherapy for Patients with Malignant Peritoneal Mesothelioma. Surgery 153.6

More information

Rachel E. Kirby, Jing Zhao, Terence Chua, Winston Liauw and David L. Morris *

Rachel E. Kirby, Jing Zhao, Terence Chua, Winston Liauw and David L. Morris * Send Orders for Reprints to reprints@benthamscience.net The Open Surgical Oncology Journal, 2014, 5, 1-5 1 Open Access Avoidance of Early Post-Operative Intraperitoneal Chemotherapy (EPIC) Following Peritonectomy

More information

INTRAOPERATIVE HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (HIPEC)

INTRAOPERATIVE HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (HIPEC) MEDICAL POLICY INTRAOPERATIVE HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (HIPEC) Policy Number: CS141.A Effective Date: September 1, 2015 Table of Contents COVERAGE RATIONALE DEFINITIONS... APPLICABLE CODES..

More information

1 page Overview. CONCURRENT 1D, 1E, 1F Biology & Pathogenesis Multi-Modality Immunology 1

1 page Overview. CONCURRENT 1D, 1E, 1F Biology & Pathogenesis Multi-Modality Immunology 1 1 page Overview 21 Oct Tuesday 1500 on REGISTRATION 1800 Welcome Reception & Cocktails at the Cape Town International Conference Centre (CTICC) 22 Oct Wednesday 0730 REGISTRATION 0830 OPENING 0900 PLENARY

More information

Comments: Policy Accepted during 2013 Annual Review with no changes.

Comments: Policy Accepted during 2013 Annual Review with no changes. Health Plan Coverage Policy ARBenefits Approval: 01/01/2012 Effective Date: 01/01/2012 Revision Date: 09/18/2013 Title: Cytoreduction Surgery with Hyperthermic Intraperitoneal Chemotherapy Comments: Policy

More information

Villejuif, Paris, France

Villejuif, Paris, France SCIENTIFIC PROGRAMME 2014 Preceptorships in oncology Aim This live educational preceptorship aims to highlight the crucial role of the multidisciplinary approach in diagnosis, treatment and management

More information

ELCC 2015 Industry Satellite Symposium The Treatment Roadmap for Squamous NSCLC. Thursday 16th April 2015 13:10 14:20 Room C

ELCC 2015 Industry Satellite Symposium The Treatment Roadmap for Squamous NSCLC. Thursday 16th April 2015 13:10 14:20 Room C ELCC 2015 Industry Satellite Symposium The Treatment Roadmap for Squamous NSCLC Thursday 16th April 2015 13:10 14:20 Room C 1 Contents Programme.... 2 Welcome message.... 3 Faculty biographies.... 4 Symposium

More information

ESO INSIDE TRACK CONFERENCE. 4 th FAMILIAL CANCER CONFERENCE. 7-8 June 2010 Madrid, Spain. Chair: J. Benítez, ES - H. Vasen, NL MADRID 07/06/10

ESO INSIDE TRACK CONFERENCE. 4 th FAMILIAL CANCER CONFERENCE. 7-8 June 2010 Madrid, Spain. Chair: J. Benítez, ES - H. Vasen, NL MADRID 07/06/10 ESO INSIDE TRACK CONFERENCE MADRID 07/06/10 4 th FAMILIAL CANCER CONFERENCE 7-8 June 2010 Madrid, Spain Chair: J. Benítez, ES - H. Vasen, NL APPLICATION AND ABSTRACT SUBMISSION Poster abstract deadline

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Hyperthermic Intraperitoneal Chemotherapy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: hyperthermic_intraperitoneal_chemotherapy 5/19/2005 3/2016 3/2017

More information

Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis in the elderly

Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis in the elderly Huang et al. World Journal of Surgical Oncology (2015) 13:262 DOI 10.1186/s12957-015-0682-7 WORLD JOURNAL OF SURGICAL ONCOLOGY RESEARCH Cytoreductive surgery and perioperative intraperitoneal chemotherapy

More information

Die multimodale Behandlung der Peritonealkarzinose

Die multimodale Behandlung der Peritonealkarzinose Die multimodale Behandlung der Peritonealkarzinose Pompiliu Piso Chirurgische Klinik der Universität Regensburg 80 Mio Inhabitans 70.000 new cases CRC/year. Henriettenstiftung Hannover Medizinische Hochschule

More information

CLINICAL ONCOLOGY MASTERCLASS IN. 25-29 April 2015 São Paulo, Brazil. Chairs: Scientific Co-ordinators: ESO - LATIN-AMERICAN PROGRAMME

CLINICAL ONCOLOGY MASTERCLASS IN. 25-29 April 2015 São Paulo, Brazil. Chairs: Scientific Co-ordinators: ESO - LATIN-AMERICAN PROGRAMME ESO - LATIN-AMERICAN PROGRAMME MASTERCLASS IN CLINICAL ONCOLOGY 25-29 April 2015 São Paulo, Brazil Chairs: N. Pavlidis, GR - R.A. Stahel, CH Scientific Co-ordinators: M. Aapro, CH - F. Cardoso, PT FOREWORD

More information

National Bowel Cancer Audit Report 2008 Public and Executive Summary

National Bowel Cancer Audit Report 2008 Public and Executive Summary National Bowel Cancer Audit Report 2008 Public and Executive Summary Prepared in association with: Healthcare Quality Improvement Partnership HQIP Association of Coloproctology of Great Britain and Ireland

More information

ESO INSIDE TRACK CONFERENCE. 4 th FAMILIAL CANCER CONFERENCE. 7-8 June 2010 Madrid, Spain. Chair: J. Benítez, ES - H. Vasen, NL MADRID 07/06/10

ESO INSIDE TRACK CONFERENCE. 4 th FAMILIAL CANCER CONFERENCE. 7-8 June 2010 Madrid, Spain. Chair: J. Benítez, ES - H. Vasen, NL MADRID 07/06/10 ESO INSIDE TRACK CONFERENCE MADRID 07/06/10 4 th FAMILIAL CANCER CONFERENCE 7-8 June 2010 Madrid, Spain Chair: J. Benítez, ES - H. Vasen, NL APPLICATION AND ABSTRACT SUBMISSION Poster abstract deadline

More information

Clinical Commissioning Policy: Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Mesothelioma

Clinical Commissioning Policy: Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Mesothelioma Clinical Commissioning Policy: Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Mesothelioma Reference: NHS England B03/P/a 1 Information Reader Box (IRB) to be inserted

More information

SUMMER SCHOOL organised by the Hepatology Committee of ESPGHAN

SUMMER SCHOOL organised by the Hepatology Committee of ESPGHAN SUMMER SCHOOL organised by the Hepatology Committee of ESPGHAN Paediatric Hepatology: from basic science to daily practice June 13-16th, 2012 Bordeaux, France Program European Society for Paediatric Gastroenterology,

More information

BOWEL CANCER. The doctor has explained that you have a growth or tumour, in your bowel or rectum and could be cancer.

BOWEL CANCER. The doctor has explained that you have a growth or tumour, in your bowel or rectum and could be cancer. Patient and Carer Information BOWEL CANCER Please read this leaflet carefully. It is important that you take note of any instructions or advice given. If you have any questions or problems that are not

More information

Population Pharmacokinetics and Pharmacodynamics of Cisplatinum During Intraperitoneal Chemohyperthermia Using a Closed Abdominal Procedure

Population Pharmacokinetics and Pharmacodynamics of Cisplatinum During Intraperitoneal Chemohyperthermia Using a Closed Abdominal Procedure Population Pharmacokinetics and Pharmacodynamics of Cisplatinum During Intraperitoneal Chemohyperthermia Using a Closed Abdominal Procedure Eddy Cotte, Brigitte Tranchand, Annie-Claude Beaujard, François-Noël

More information

CANCERS OF THE PERITONEUM PERITONEAL MESOTHELIOMA PREFERRED MODEL OF CARE AND CRITERIA FOR REFERENCE CENTRES

CANCERS OF THE PERITONEUM PERITONEAL MESOTHELIOMA PREFERRED MODEL OF CARE AND CRITERIA FOR REFERENCE CENTRES CANCERS OF THE PERITONEUM PERITONEAL MESOTHELIOMA PREFERRED MODEL OF CARE AND CRITERIA FOR REFERENCE CENTRES Coordinator: Alex Kartheuser (Colorectal Surgery, Cliniques universitaires St-Luc, UCL) Authors

More information

SKIN MELANOMA. 27-28 September 2006, Istanbul, TR

SKIN MELANOMA. 27-28 September 2006, Istanbul, TR ESO SEMINARES SKIN MELANOMA 27-28 September 2006, Istanbul, TR Chair: N. Cascinelli, IT - A.M.M. Eggermont, NL - S. Kurul, TR Host Chair: M. Erkisi, TR - F. Tas, TR Co-ordinators: G. Demir, TR - H. Camlica,

More information

National Medical Policy

National Medical Policy National Medical Policy Subject: Policy Number: Intraperitoneal Hyperthermic Chemotherapy for Abdominopelvic Cancers NMP346 Effective Date*: June 2007 Updated: November 2014 This National Medical Policy

More information

TEACH Summer School Cascais, Portugal 3-7 July, 2016. Training and Education for Advanced Clinicians and HCPs in Personalised Medicine

TEACH Summer School Cascais, Portugal 3-7 July, 2016. Training and Education for Advanced Clinicians and HCPs in Personalised Medicine TEACH Summer School Cascais, Portugal 3-7 July, 2016 Training and Education for Advanced Clinicians and HCPs in Personalised Medicine TEACH Summer School Cascais, Portugal 3-7 July, 2016 Objectives There

More information

Scientific Committee Hilary Calvert UCL Cancer Institute, London, United Kingdom

Scientific Committee Hilary Calvert UCL Cancer Institute, London, United Kingdom Scientific Committee Hilary Calvert UCL Cancer Institute, London, United Kingdom Luca Gianni Fondazione Centro San Raffaele del Monte Tabor, Milan, Italy Ana Maria Gonzalez-Angulo M.D. Anderson Cancer

More information

Clinical Commissioning Policy: Cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Mesothelioma

Clinical Commissioning Policy: Cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Mesothelioma Clinical Commissioning Policy: Cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Mesothelioma Reference: NHS England A08/P/c 2 NHS England INFORMATION READER BOX Directorate

More information

REPORT ON STOMA SERVICE AND PRACTICE. MM / YY to MM / YY. Name: Title: Centre:

REPORT ON STOMA SERVICE AND PRACTICE. MM / YY to MM / YY. Name: Title: Centre: REPORT ON STOMA SERVICE AND PRACTICE MM / YY to MM / YY Name: Title: Centre: 1 Contents 1.0 Introduction 2.0 Aims of the Stoma Care Service 3.0 Clinical Activity 4.0 Cost Saving Measures 5.0 Education

More information

Clinical Commissioning Policy: Cytoreduction surgery for patients with peritoneal carcinomatosis April 2013. Reference : NHSCB/A08/P/a

Clinical Commissioning Policy: Cytoreduction surgery for patients with peritoneal carcinomatosis April 2013. Reference : NHSCB/A08/P/a Clinical Commissioning Policy: Cytoreduction surgery for patients with peritoneal carcinomatosis April 2013 Reference : NHS Commissioning Board Clinical Commissioning Policy for Cytoreduction surgery for

More information

H. Richard Alexander, Jr., M.D. Department of Surgery and The Greenebaum Cancer Center University of Maryland School of Medicine Baltimore, Md

H. Richard Alexander, Jr., M.D. Department of Surgery and The Greenebaum Cancer Center University of Maryland School of Medicine Baltimore, Md Major Advances in Cancer Prevention, Diagnosis and Treatment~ Why Mesothelioma Leads the Way H. Richard Alexander, Jr., M.D. Department of Surgery and The Greenebaum Cancer Center University of Maryland

More information

GRANT APPLICATION FORM: ORGANISING AN ESO EDUCATIONAL EVENT

GRANT APPLICATION FORM: ORGANISING AN ESO EDUCATIONAL EVENT GRANT APPLICATION FORM: ORGANISING AN ESO EDUCATIONAL EVENT 1) TOPIC OF THE EVENT MALIGNANT PLEURAL DISEASE 2) SUGGESTED TITLE : Approach to Pleural Cancer: State-of-the-Art 3) TYPE OF EVENT Course Native

More information

IN MANY PATIENTS WITH ABDOMINAL OR PELVIC MALIGNANCIES, surgical treatment

IN MANY PATIENTS WITH ABDOMINAL OR PELVIC MALIGNANCIES, surgical treatment Sugarbaker, Cancerología 3 (2008): 119-124 1 Washington Cancer Institute, Washington, DC, USA Overview of Peritoneal Carcinomatosis Paul H. Sugarbaker 1 Abstract IN MANY PATIENTS WITH ABDOMINAL OR PELVIC

More information

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY Original Issue Date (Created): July 1, 2002 Most Recent Review Date (Revised): July 22, 2014 Effective Date: October 1, 2014 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT

More information

COMMISSIONING. for ULTRA-RADICAL SURGERY ADVANCED OVARIAN CANCER

COMMISSIONING. for ULTRA-RADICAL SURGERY ADVANCED OVARIAN CANCER COMMISSIONING for ULTRA-RADICAL SURGERY in ADVANCED OVARIAN CANCER WHY THIS MUST HAPPEN PERSPECTIVE COMMISSIONING FOR WHO, FOR WHAT? Biological Basis Surgical Basis International and national standards

More information

GYNAECOLOGICAL ONCOLOGY MULTIDISCIPLINARY TEAM MEETINGS: OPERATIONAL POLICY Version 3

GYNAECOLOGICAL ONCOLOGY MULTIDISCIPLINARY TEAM MEETINGS: OPERATIONAL POLICY Version 3 GYNAECOLOGICAL ONCOLOGY MULTIDISCIPLINARY TEAM MEETINGS: OPERATIONAL POLICY Version 3 Policy agreed Sept 2009 (updated Jan/Feb 2013) Agreed by: SCAN gynae group 2009 Update agreed SCAN gynae group May

More information

Columbia University Mesothelioma Applied Research Foundation - 2009 - www.curemeso.org. Mesothelioma Center www.mesocenter.org

Columbia University Mesothelioma Applied Research Foundation - 2009 - www.curemeso.org. Mesothelioma Center www.mesocenter.org Columbia University Mesothelioma Center www.mesocenter.org Multimodal clinical trials, treatment (surgery, radiation, chemotherapy) Peritoneal mesothelioma program Immunotherapy translational, experimental

More information

Monitoring Clinical Stage to Improve Care

Monitoring Clinical Stage to Improve Care Monitoring Clinical Stage to Improve Care Stephen Dreyer, MD, FACS Cancer Liaison State Chair Nebraska Fremont, NE M. Asa Carter, CTR Manager, Accreditation and Standards American College of Surgeons Chicago,

More information

Mesothelioma in the UK

Mesothelioma in the UK Mesothelioma in the UK Liz Darlison Mesothelioma UK The National Macmillan Mesothelioma Resource Centre June 2010 Mesothelioma Applied Research Foundation - 2010 www.curemeso.org Contents Size of Mesothelioma

More information

CANCER IN THE ELDERLY

CANCER IN THE ELDERLY ESO ADVANCED COURSES AND SEMINARS In collaboration with: CANCER IN THE ELDERLY 5-6 May 2006, Maastricht Chair: R.A. Audisio, UK - J.W.W. Coebergh, NL Under the auspices of: FRIDAY 5 MAY 08:15 Registration

More information

Information for Men Diagnosed with Testicular Cancer

Information for Men Diagnosed with Testicular Cancer Patient Information Service Information for Men Diagnosed with Testicular Cancer Bristol Haematology and Oncology Centre Bristol Testicular Cancer Service Patient Information is supported by September

More information

Multi-institutional experience of diffuse intra-abdominal multicystic peritoneal mesothelioma

Multi-institutional experience of diffuse intra-abdominal multicystic peritoneal mesothelioma Original article Multi-institutional experience of diffuse intra-abdominal multicystic peritoneal mesothelioma T. C. Chua 1,T.D.Yan 1,2, M. Deraco 3,O.Glehen 4,B.J.Moran 5 and P. H. Sugarbaker 6,onbehalf

More information

Peritoneal Carcinosis

Peritoneal Carcinosis Peritoneal Carcinosis What is it and how to cure it Peritoneum Peritoneum is a thin and transparent membrane that covers the internal part of the abdominal and pelvic cavity and all the viscera contained

More information

Fact sheet 10. Borderline ovarian tumours. The difficult cases. What is borderline ovarian cancer (BOC)?

Fact sheet 10. Borderline ovarian tumours. The difficult cases. What is borderline ovarian cancer (BOC)? For this reason, some doctors prefer the term borderline ovarian tumour rather than borderline ovarian cancer. Fact sheet 10 Borderline ovarian tumours We, Ovacome, are a support network for people affected

More information

Program Chairs: Robert W. Holloway, MD and Martin Martino, MD Speakers and times are subject to change

Program Chairs: Robert W. Holloway, MD and Martin Martino, MD Speakers and times are subject to change FRIDAY, FEBRUARY 20, 2015 Program Chairs: and Martin Martino, MD Speakers and times are subject to change 6:00 a.m. 6:00 p.m. Registration/Information Desk /L Foyer 6:00 a.m. 6:00 p.m. Speaker Ready Area

More information

Scientific Programme

Scientific Programme Scientific Programme Scientific Committee Hilary Calvert UCL Cancer Institute, London, UK Luca Gianni Ospedale San Raffaele IRCCS, Milan, Italy Ana Maria Gonzalez-Angulo Cristiana Sessa Istituto Oncologico

More information

Departments of Nuclear Medicine, Surgery, and Endocrinology University of Ulm

Departments of Nuclear Medicine, Surgery, and Endocrinology University of Ulm 4 th Würzburg Summer School of Thyroid Cancer Management A training course on basics, diagnosis and therapy of differentiated thyroid tumours under the auspices of the European Association of Nuclear Medicine

More information

Gentofte Workshop 2013

Gentofte Workshop 2013 Gentofte Workshop 2013 Copenhagen University Hospital Gentofte, Denmark Basic course in CT guided lung biopsy 13th and 14th of June, 2013 Dear colleagues It is a pleasure to invite you to our fourth basic

More information

Laparoscopic Hyperthermic Intraperitoneal Chemotherapy: Indications, Aims, and Results: A Systematic Review of the Literature

Laparoscopic Hyperthermic Intraperitoneal Chemotherapy: Indications, Aims, and Results: A Systematic Review of the Literature Ann Surg Oncol DOI 10.1245/s10434-012-2360-0 ORIGINAL ARTICLE REVIEW ARTICLE Laparoscopic Hyperthermic Intra Chemotherapy: Indications, Aims, and Results: A Systematic Review of the Literature Enrico Facchiano,

More information

FRIDAY MAY 9, 2014. Seattle, WA

FRIDAY MAY 9, 2014. Seattle, WA FRIDAY MAY 9, 2014 ORIN SMITH AUDITORIUM UW Medicine south lake union campus Seattle, WA Course Description This symposium is designed to bring state of the art information on current research and clinical

More information

EMRI ERASMUS COURSE ON MAGNETIC RESONANCE. MRI Abdominal Module

EMRI ERASMUS COURSE ON MAGNETIC RESONANCE. MRI Abdominal Module EMRI ERASMUS COURSE ON MAGNETIC RESONANCE MRI Abdominal Module September, 23-26, 2015 Coimbra, Portugal LOCAL ORGANIZERS F Caseiro-Alves L Curvo-Semedo Dear Colleagues: It is our pleasure to receive you

More information

Treating Mesothelioma - A Quick Guide

Treating Mesothelioma - A Quick Guide Treating Mesothelioma - A Quick Guide Contents This is a brief summary of the information on Treating mesothelioma from CancerHelp UK. You will find more detailed information on the website. In this information

More information

OVARIAN CANCER TREATMENT

OVARIAN CANCER TREATMENT OVARIAN CANCER TREATMENT Cancer Care Pathways Directorate Tailored Information in Cancer Care (TICC) Sir Anthony Mamo Oncology Centre National Cancer Plan May 2015 Contents About this booklet 1 The Ovaries

More information

INTRAPERITONEAL HYPERTHERMIC CHEMOTHERAPY (IPHC) FOR PERITONEAL CARCINOMATOSIS AND MALIGNANT ASCITES. INFORMATION FOR PATIENTS AND FAMILY MEMBERS

INTRAPERITONEAL HYPERTHERMIC CHEMOTHERAPY (IPHC) FOR PERITONEAL CARCINOMATOSIS AND MALIGNANT ASCITES. INFORMATION FOR PATIENTS AND FAMILY MEMBERS INTRAPERITONEAL HYPERTHERMIC CHEMOTHERAPY (IPHC) FOR PERITONEAL CARCINOMATOSIS AND MALIGNANT ASCITES. INFORMATION FOR PATIENTS AND FAMILY MEMBERS Description of Treatment A major difficulty in treating

More information

J Clin Oncol 27:6237-6242. 2009 by American Society of Clinical Oncology INTRODUCTION

J Clin Oncol 27:6237-6242. 2009 by American Society of Clinical Oncology INTRODUCTION VOLUME 27 NUMBER 36 DECEMBER 20 2009 JOURNAL OF CLINICAL ONCOLOGY O R I G I N A L R E P O R T Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma:

More information

Gentofte Workshop. Gentofte. Hospital 10/2012. University. Training Centre

Gentofte Workshop. Gentofte. Hospital 10/2012. University. Training Centre Gentofte Workshop 10/2012 Gentofte University Hospital EUS and EBUS Training Centre Basic course in interventional endosonography for lung diseases 1st and 2nd October 2012 Dear colleagues, It is a pleasure

More information

Mapping quality assurance approaches in Europe

Mapping quality assurance approaches in Europe Mapping quality assurance approaches in Europe Reinhard Busse (with Helena Legido-Quigley & Martin McKee) Professor of Health Care Management, Technische Universität Berlin European Observatory on Health

More information

Cancer Survivorship Care

Cancer Survivorship Care 1113 Prog FOCUS BERGAMO.qxp 3-09-2013 10:22 Pagina 1 Menarini Foundation Symposia: 000 Focus on Rare Diseases: Cancer Survivorship Care Bergamo (Italy), November 14 th - 16 th, 2013 Organized by CLINICAL

More information

E UROPEAN PERSONAL INFORMATION

E UROPEAN PERSONAL INFORMATION E UROPEAN CURRICULUM VITAE FORMAT PERSONAL INFORMATION Name Work Address ARTURO CHITI Humanitas University, Via A. Manzoni 113, 20089 Rozzano (MI), Italy Nuclear Medicine Department, Humanitas Research

More information

Healthcare Management

Healthcare Management 5-7 May 2015 Gallagher Convention Centre, Midrand, Johannesburg, OFFICIAL CHARITY 2015 Healthcare Management Conference ALL REGISTRATION FEES FROM THE CONFERENCES WILL BE DONATED TO THE STEPS CHARITY 5

More information

Clinical Policy Bulletin: Hyperthermia in Cancer Therapy

Clinical Policy Bulletin: Hyperthermia in Cancer Therapy Hyperthermia in Cancer Therapy Page 1 of 28 Aetna Better Health 2000 Market Street, Suite 850 Philadelphia, PA 19103 AETNA BETTER HEALTH Clinical Policy Bulletin: Hyperthermia in Cancer Therapy Number:

More information

How do I find the best place to get treatment for my lymphoma?

How do I find the best place to get treatment for my lymphoma? Produced November 2010 Next revision due November 2012 How do I find the best place to get treatment for my lymphoma? Introduction Fortunately this is not a question that patients with cancers of the blood

More information

EUTHANASIA IN EUROPE FIRST EUROPEAN SYMPOSIUM ON EUTHANASIA AND ASSISTED SUICIDE EDINBURGH CONFERENCE CENTRE

EUTHANASIA IN EUROPE FIRST EUROPEAN SYMPOSIUM ON EUTHANASIA AND ASSISTED SUICIDE EDINBURGH CONFERENCE CENTRE CARENOTKILLING 6-8 SEPTEMBER 2012 FIRST EUROPEAN SYMPOSIUM ON EUTHANASIA AND ASSISTED SUICIDE EDINBURGH CONFERENCE CENTRE EUTHANASIA IN EUROPE WHERE HAVE WE COME FROM AND WHERE ARE WE GOING? CARENOTKILLING

More information

Salisbury Lung Cancer Service (1 of 5)

Salisbury Lung Cancer Service (1 of 5) Salisbury Lung Cancer Service (1 of 5) i If you need this information in another language or medium (audio, large print, etc) please contact Customer Care on 0800 374 208 email: customercare@ salisbury.nhs.uk.

More information

Gynaecological Cancers 2015

Gynaecological Cancers 2015 Gynaecological Cancers 2015 Annex D Epidemiology 1. It is estimated that there will be an increase in the incidence of gynaecological cancers by 2015. For example: a. The incidence of cervical cancer is

More information

EORTC MELANOMA GROUP MEETING

EORTC MELANOMA GROUP MEETING EORTC MELANOMA GROUP MEETING April 29th-30th, 2016 MILAN - ITALY Istituto Europeo di Oncologia via Ripamonti 435, Milan Host AlessandroTestori Istituto Europeo di Oncologia, Milan, Italy Group Chair Caroline

More information

British Thoracic Oncology Group (BTOG) Annual Report - April 2014 to March 2015

British Thoracic Oncology Group (BTOG) Annual Report - April 2014 to March 2015 0116 250 2811 dawn.mckinley@uhl-tr.nhs.uk www.btog.org @BTOGORG British Thoracic Oncology Group (BTOG) Annual Report - April 2014 to March 2015 BTOG s Aim BTOG is the multi-disciplinary group for professionals

More information

THORACIC ONCOLOGY MULTIDISCIPLINARY TEAM MEETINGS: OPERATIONAL POLICY

THORACIC ONCOLOGY MULTIDISCIPLINARY TEAM MEETINGS: OPERATIONAL POLICY THORACIC ONCOLOGY MULTIDISCIPLINARY TEAM MEETINGS: OPERATIONAL POLICY EXECUTIVE SUMMARY 1. All patients in Lothian with thoracic malignancies should be discussed at designated times in pathway (see App

More information

PRODYNOV. Targeted Photodynamic Therapy of Ovarian Peritoneal Carcinomatosis ONCO-THAI. Image Assisted Laser Therapy for Oncology

PRODYNOV. Targeted Photodynamic Therapy of Ovarian Peritoneal Carcinomatosis ONCO-THAI. Image Assisted Laser Therapy for Oncology PRODYNOV Targeted Photodynamic Therapy of Ovarian Peritoneal Carcinomatosis ONCO-THAI Image Assisted Laser Therapy for Oncology Inserm ONCO-THAI «Image Assisted Laser Therapy for Oncology» Inserm ONCO-THAI

More information

STRESA 31/03/11 RARE SOLID CANCERS: AN INTRODUCTION. 31 March - 1 April 2011 Stresa, Italy. Chairs: P.G. Casali, IT - G. Gatta, IT

STRESA 31/03/11 RARE SOLID CANCERS: AN INTRODUCTION. 31 March - 1 April 2011 Stresa, Italy. Chairs: P.G. Casali, IT - G. Gatta, IT ESO ADVANCED COURSES, SEMINARS AND SYMPOSIA 31/03/11 RARE SOLID CANCERS: AN INTRODUCTION 31 March - 1 April 2011 Stresa, Italy Chairs: P.G. Casali, IT - G. Gatta, IT STRESA In collaboration with COURSE

More information

Richmond meets Salzburg

Richmond meets Salzburg Richmond meets Salzburg A Foregut and Bariatric Surgery Symposium Thursday 10 th till Friday 11 th of December 2015 Salzburg Congress 122 nd educational meeting in cooperation with the Austrian Society

More information

Gynecologic Cancer in Women with Lynch Syndrome

Gynecologic Cancer in Women with Lynch Syndrome Gynecologic Cancer in Women with Lynch Syndrome Sarah E. Ferguson, MD FRCSC Division of Gynecologic Oncology, Princess Margaret Hospital, University of Toronto June 11, 2013 Objective 1. To review the

More information

ORGANIZERS Fundación para la Investigación Médica Aplicada FIMA Clínica Universidad de Navarra CUN

ORGANIZERS Fundación para la Investigación Médica Aplicada FIMA Clínica Universidad de Navarra CUN D International Symposium: Immunostimulatory monoclonal antibodies and immunomodulation: harvesting the crop Fundación Ramón Areces GENERAL INFORMATION DATES OCTOBER 18th 20th VENUE University of Navarra.

More information

Professional Managers Annual Conference Adding value to business schools Programme

Professional Managers Annual Conference Adding value to business schools Programme Professional Managers Annual Conference Adding value to business schools Programme 3-4 December 2015, Regent s University London Professional Managers Annual Conference 2015 - Adding value to business

More information

Cytoreduction and Intraperitoneal Chemotherapy for the Management of Non-Gynecological Peritoneal Surface

Cytoreduction and Intraperitoneal Chemotherapy for the Management of Non-Gynecological Peritoneal Surface J. Exp. Clin. Cancer Res., 22, 4, 2003 - Supplement Cytoreduction and Intraperitoneal Chemotherapy for the Management of Non-Gynecological Peritoneal Surface Malignancy Yan T.D., Esquivel J., Carmignani

More information

A succesfull case of HIPEC in a peritoneal mesothelioma patient

A succesfull case of HIPEC in a peritoneal mesothelioma patient A succesfull case of HIPEC in a peritoneal mesothelioma patient Firmino, NLJ¹²; Miranda, E¹³; Oliveira, DA ²; Lima, MBA ¹²; Diniz, AF ¹²; Gomes, GES ¹²; Azevedo, LW ¹²; Soares,MC¹²; Gomes, ASA³. ¹Pernambuco

More information

Best of the Annual Conferences in Digestive Diseases

Best of the Annual Conferences in Digestive Diseases THE UNIVERSITY OF CHICAGO MEDICINE Department of Medicine and the Digestive Diseases Center Best of the Annual Conferences in Digestive Diseases Saturday, June 11, 2016 7:30 am 5:00 pm CONFERENCE CO-DIRECTORS

More information

Please see the LUCADA data manual v3.1.3, available in the downloads section

Please see the LUCADA data manual v3.1.3, available in the downloads section National Lung Cancer Audit Frequently Asked Questions What dataset should be used? Please see the LUCADA data manual v3.1.3, available in the downloads section What does LUCADA stand for? LUCADA stands

More information

Description of the live educational event

Description of the live educational event Description of the live educational event Title Venue Date(s) Duration of the event Please provide detailed information on the duration of the LEE. Target audience To be explained in terms of the speciality/ies

More information

FAMILIAL CANCER ESO, CNIO AND NRCO CONFERENCE ON. 19-20 May 2016 Madrid, Spain. Chairs: R. Eeles, UK W.D. Foulkes, CA M. Robledo, ES H.

FAMILIAL CANCER ESO, CNIO AND NRCO CONFERENCE ON. 19-20 May 2016 Madrid, Spain. Chairs: R. Eeles, UK W.D. Foulkes, CA M. Robledo, ES H. INSIDE TRACK CONFERENCE ESO, CNIO AND NRCO CONFERENCE ON FAMILIAL CANCER 19-20 May 2016 Madrid, Spain Chairs: R. Eeles, UK W.D. Foulkes, CA M. Robledo, ES H. Vasen, NL FOREWORD The ESO, CNIO and NRCO Conference

More information

Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Mesothelioma

Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Mesothelioma Original Article 291 Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Mesothelioma Grace HC Tan, 1 MBBS (London), MRCS (Edinburgh), Michelle Cheung, 1 MBBCh

More information

Understanding CA 125 Levels A GUIDE FOR OVARIAN CANCER PATIENTS. foundationforwomenscancer.org

Understanding CA 125 Levels A GUIDE FOR OVARIAN CANCER PATIENTS. foundationforwomenscancer.org Understanding CA 125 Levels A GUIDE FOR OVARIAN CANCER PATIENTS foundationforwomenscancer.org Contents Introduction...1 CA 125................................... 1 The CA 125 Test...2 The Use of the CA

More information